<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF"><gtr:id>E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF</gtr:id><gtr:name>University of Seville</gtr:name><gtr:address><gtr:line1>Avda</gtr:line1><gtr:line2>Reina Mercedes, S/n</gtr:line2><gtr:line4>E-41012 Seville</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/303E2392-4064-48A4-99F4-4ADB9D75C377"><gtr:id>303E2392-4064-48A4-99F4-4ADB9D75C377</gtr:id><gtr:name>St George's Hospital</gtr:name><gtr:address><gtr:line1>Blackshaw Road</gtr:line1><gtr:line2>Tooting</gtr:line2><gtr:postCode>SW17 0QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/303E2392-4064-48A4-99F4-4ADB9D75C377"><gtr:id>303E2392-4064-48A4-99F4-4ADB9D75C377</gtr:id><gtr:name>St George's Hospital</gtr:name><gtr:address><gtr:line1>Blackshaw Road</gtr:line1><gtr:line2>Tooting</gtr:line2><gtr:postCode>SW17 0QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF"><gtr:id>E3BB202F-E9D1-4FB6-B29C-A98ED2C9AECF</gtr:id><gtr:name>University of Seville</gtr:name><gtr:address><gtr:line1>Avda</gtr:line1><gtr:line2>Reina Mercedes, S/n</gtr:line2><gtr:line4>E-41012 Seville</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/272F8C15-329A-4E57-8F25-7EA3E44849A9"><gtr:id>272F8C15-329A-4E57-8F25-7EA3E44849A9</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137884182"><gtr:id>EB49EB8F-6611-4445-B6AC-0B4C6C24F773</gtr:id><gtr:title>Mechanisms of leukocyte and tumour cell trafficking in the lymphatic system</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137884182</gtr:grantReference><gtr:abstractText>The lymphatic network is a second circulatory system as extensive as the blood system that acts as a conduit for fluid drainage as well as a pipeline for the delivery of foreign antigens to the lymph nodes - the sites where protective immune responses are generated. The lymphatic system is also exploited by cancers which frequently use it to spread from the primary tumour to distant organs. Understanding how cells enter and exit the lymphatics and learning how to block these processes would benefit treatments for inflammation _ where the immune response needs to be damped down, as well as treatments for bowel, breast and other common cancers where lymphatic spread prevents control of the disease. The work being carried out by this group involves studying the mechanisms for cell entry to lymphatic vessels at the molecular level using materials isolated from patients as well as animal models for inflammation and cancer.</gtr:abstractText><gtr:technicalSummary>This project addresses the fundamental question of how leukocytes - particularly antigen presenting dendritic cells, memory T cells and neutrophils enter the lymphatics and migrate to draining lymph nodes in the course of the immune response to foreign antigen. It also concerns the important related issue of how tumour cells disseminate to lymph nodes and distant organs via the lymphatics during the process of metastasis. The methodology involves the isolation and culture of lymphatic endothelial cells from patients and their analysis in a range of cell migration, cell adhesion, chemotaxis and gene chip microarray (transcriptional profiling) studies. In addition, the research involves immunohistochemical and microscopic studies of lymphatic vessel organization in human and murine cancer specimens, lymphatic trafficking studies in mouse models of inflammation and cancer, and gene knockout analyses. The work involves collaboration with surgeons, clinicians and pathologists at the Oxford Radcliffe site, as well as in-house expertise from clinician D.Phil students and DoH Clinical Research Development Awardees (RDAs). The work is likely to reveal targets for the blockade of immune activation in the treatment of inflammation and the induction of immunosuppression as well as providing information for optimizing vaccine delivery. Furthermore, the work is likely to identify new prognostic markers for prediction of lymphogenic tumour metastasis in head and neck squamous cell carcinoma and colorectal carcinoma and may also identify targets for blockade of lymph node metastasis in these as well as other human cancers.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2367084</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Molecular Biosciences</gtr:department><gtr:description>Anne Dell collboration</gtr:description><gtr:id>8D4ACA4C-CD9F-4A97-A5E1-E46D1B0D9467</gtr:id><gtr:impact>Expertise in glycan analysis for core projects and future publications</gtr:impact><gtr:outcomeId>ATTeRM4me1R-1</gtr:outcomeId><gtr:partnerContribution>Expertise in analysis of regulatory carbohydrate components of key glycoproteins in our research</gtr:partnerContribution><gtr:piContribution>Preparation of materials for glycan analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nick Athanasou collaboration</gtr:description><gtr:id>CD36AA8D-7B88-42BC-92C9-46B038B2751D</gtr:id><gtr:impact>Several co-authored publications
PMID 19727710; 18813946;18484257;17904616</gtr:impact><gtr:outcomeId>q5Jed3vfumf-1</gtr:outcomeId><gtr:partnerContribution>Research into clinicopathology of lymphatics in connective tissue</gtr:partnerContribution><gtr:piContribution>Generated and provided antibodies for immunohistochemistry Provided advice and expertise in microscopy and intellectual contribution towards publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>David Greaves collaboration</gtr:description><gtr:id>38CEC972-FF2E-4B3C-AA1C-9BCC52B5CA3D</gtr:id><gtr:impact>Manuscript in Blood; describing utility of CD68 transgenic reporter mice for macrophage trafficking studies

Manuscript in preparation for J Biol Chem</gtr:impact><gtr:outcomeId>TijfaW5VJgu-1</gtr:outcomeId><gtr:partnerContribution>Advice and expertise in measurement of endothelial cell junctional permeability
Contribution of transgenic reporter mice</gtr:partnerContribution><gtr:piContribution>Intellectual input and experimental design
Animal experiments involving cell trafficking</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Seville</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Department of Bioorganic Chemistry</gtr:department><gtr:description>Jesus Angulo NMR collaboration</gtr:description><gtr:id>A2CFA7B0-3E6F-42FA-8121-53691CED5BD2</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>Qf6vTwf4Doq-1</gtr:outcomeId><gtr:partnerContribution>Performed STD NMR analyses</gtr:partnerContribution><gtr:piContribution>Provision of recombinant soluble CD44 protein for STD NMR experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Clinical Institute of Pathology</gtr:department><gtr:description>Fluorescence and EM imaging of lung</gtr:description><gtr:id>6AA86EED-6A97-44D0-8CEC-E2F0B97C8E3F</gtr:id><gtr:impact>Obtained important data for inclusion in manuscript under preparation for publication in scientific journal</gtr:impact><gtr:outcomeId>eAEkX4Sqdfz-1</gtr:outcomeId><gtr:partnerContribution>Performed immunoelectron microscopy and immunofluorescence imaging of thin sections of mouse alveolae</gtr:partnerContribution><gtr:piContribution>Provision of reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Luxheng Xue collaboration</gtr:description><gtr:id>92122FF6-30E6-4161-9CFA-8C45D7FFD737</gtr:id><gtr:impact>Manuscript in J allergy and Clinical Immunol PMID 25441644</gtr:impact><gtr:outcomeId>5461055a756bb7.41898604-1</gtr:outcomeId><gtr:partnerContribution>Performance of experiments to investigate neutrophil : T cell crosstalk</gtr:partnerContribution><gtr:piContribution>Advice and experimental design. Discussion of data and manuscript editing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Anatomy</gtr:department><gtr:description>High Resolution confocal Lung Imaging</gtr:description><gtr:id>C36C71A6-D98E-4B24-8585-A0151AB609A3</gtr:id><gtr:impact>Obtained critical data for inclusion in a manuscript under preparation for submission to scientific journal</gtr:impact><gtr:outcomeId>CV8nNG1aY1q-1</gtr:outcomeId><gtr:partnerContribution>Carried out perfusion fixation and inflation of lungs and prepared sections for confocal imaging and z sectioning to identify critical cell population in alveolae</gtr:partnerContribution><gtr:piContribution>Provided reagents and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Surface Plasmon resonance (Biacore) analysis of receptor ligand binding affinity</gtr:description><gtr:id>1E1DBFDD-8E84-4CEE-8DD7-CF0CABBD12F5</gtr:id><gtr:impact>Manuscript that is about to be submitted to J Biol Chem</gtr:impact><gtr:outcomeId>5460ffca8f8ec4.14636731-1</gtr:outcomeId><gtr:partnerContribution>Mathematical evaluation of binding data from kinetic analyses and derivation of accurate Kd values</gtr:partnerContribution><gtr:piContribution>Generated recombinant soluble hyaluronan receptors and mutants thereof and performed Biacore analyses using hyaluronan coated chip to determine binding affinities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Infection and Immunity</gtr:department><gtr:description>Awen Gallimore collaboration</gtr:description><gtr:id>FE2E4CB0-EB0B-4147-AFB6-EC42CC367151</gtr:id><gtr:impact>Manuscript in International Journal of Cancer PMID 24142504</gtr:impact><gtr:outcomeId>546103abaf7688.68084246-1</gtr:outcomeId><gtr:partnerContribution>Carried out studies into mouse fibrosarcoma tumour development and role of different vasculatures in T cell recruitment to tumour</gtr:partnerContribution><gtr:piContribution>Advice on experimental design and evaluation of experimental data from mouse tumour model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Clinical Institute of Pathology</gtr:department><gtr:description>Lung lymphatics mAbs</gtr:description><gtr:id>BFB0B848-4DFE-4962-B51E-B1BB1BBB7F97</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>odRMoy6WnDr-1</gtr:outcomeId><gtr:partnerContribution>EM and confocal imaging of lung vasculature</gtr:partnerContribution><gtr:piContribution>Generation of mAbs for imaging vasculature in lung sections</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Sriskandan collaboration</gtr:description><gtr:id>A8042CFD-A388-4760-9C6F-56E8AD6FFEA4</gtr:id><gtr:impact>Publication in PLoS Pathogens 2015 PMID 26352587 

Multidsciplinary

Immunology
Bacteriology
Infectious Diseases</gtr:impact><gtr:outcomeId>azvmk1hfP3y-1</gtr:outcomeId><gtr:partnerContribution>Provision of wild-type and mutant strains of Strep pyogenes and participation of post-doctoral scientist</gtr:partnerContribution><gtr:piContribution>Design of experiments and advise on performing experiments to assess interactions between hyaluronan encapsulated Group A strep and lymphatic endothelial cells leading to possible transport to lymph nodes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>Fiona Powrie collaboration IBD</gtr:description><gtr:id>62D9FBBD-8A3D-476D-97A1-AA186CC8698B</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>B5TfcFvaTTa-1</gtr:outcomeId><gtr:partnerContribution>Expertise and advice in Mouse models of inflammatory bowel disease. Intellectual input.</gtr:partnerContribution><gtr:piContribution>Intellectual input, experimental design. Provision of function blocking mAbs and gene knockout mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Dermatology</gtr:department><gtr:description>Peter Mortimer collaboration</gtr:description><gtr:id>4D43E0A3-629F-4AFC-83CD-4F132A0F8D55</gtr:id><gtr:impact>Ongoing characterization of pathology of lymphoedemas</gtr:impact><gtr:outcomeId>eotHrk5z6dy-1</gtr:outcomeId><gtr:partnerContribution>Broadened knowledge of clinical issues in lymphatic disease</gtr:partnerContribution><gtr:piContribution>Generated antibodies and provided advice and intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Neil Barclay and Clive Metcalf CD44 labile sulphydryl collaboration</gtr:description><gtr:id>4D707AC1-7119-4D4A-9E47-A5645E9B0147</gtr:id><gtr:impact>Manuscript that is about to be submitted to J Biol Chem</gtr:impact><gtr:outcomeId>iabFu1Wr8qi-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input. Experimental design. Mass spectrometric analysis of reduced CD44 protein adducts and reagent sharing.</gtr:partnerContribution><gtr:piContribution>Intellectual input. Experimental design. Analysis of CD44 molecules before and after selective reduction to identify labile sulphydryls and the effects of their reduction on ligand (HA) binding by surface plasmon resonance measurement and cellular assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>Super resolution microscopy</gtr:description><gtr:id>9AD4166E-BD76-4BB4-A2A9-4060C7688822</gtr:id><gtr:impact>Multidisciplinary collaboration
Manuscript submitted to Scientific Reports 2016</gtr:impact><gtr:outcomeId>54610186226fb4.64420725-1</gtr:outcomeId><gtr:partnerContribution>Performing STED microscopy and analysis of data</gtr:partnerContribution><gtr:piContribution>Preparation of primary cells and transfectants, and appropriate mAbs and conjugates for STED microscopic evaluation of receptor surface distribution</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Institute of Bioengineering</gtr:department><gtr:description>Melody Swartz collaboration</gtr:description><gtr:id>34DB27E4-227D-4A51-B0C5-8767FAEA61F8</gtr:id><gtr:impact>Transfer of specialist expertise</gtr:impact><gtr:outcomeId>SyW8EA6yY1w-1</gtr:outcomeId><gtr:partnerContribution>Training in the immunoisolation of lymphatic endothelial cells from mice using podoplanin mAbs. Training in intravital imaging of lymphatics.</gtr:partnerContribution><gtr:piContribution>Travel to partners laboratory for training</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>Simon Milling collaboration</gtr:description><gtr:id>60AF68EE-F754-402B-B279-1D9DA54656CA</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>rfpqoeDajYo-1</gtr:outcomeId><gtr:partnerContribution>Provision of expertise in surgical techniques and sampling of pseudoafferent lymph in mice. Intellectual input. Mouse models of gut inflammation.</gtr:partnerContribution><gtr:piContribution>Design of experiments to assess lymphatic trafficking from intestine by sampling afferent lymph in mice. Contribution of function blocking mAbs and knockout mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Molecular Biomedicine</gtr:department><gtr:description>Dietmar Vestweber collaboration</gtr:description><gtr:id>85E848F6-3D66-45E0-A5C9-626C4BC583CA</gtr:id><gtr:impact>Generated publication PMID 18794116 Allowed us to obtain transgenic mice for future mechanistic studies</gtr:impact><gtr:outcomeId>aCwT5idQawc-1</gtr:outcomeId><gtr:partnerContribution>Allowed us to obtain transgenic mice for future mechanistic studies</gtr:partnerContribution><gtr:piContribution>Application of antibody reagents to characterization of tumour lymphatics. Intellectual input into experiments</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant Neutrophil trafficking in lymphatics</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1100134</gtr:fundingRef><gtr:id>A7E3DFC0-0E9C-40E1-8EF7-E84AD6B56C86</gtr:id><gtr:outcomeId>kV2idpofnWg0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>592795</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant Streptococcal dissemination</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L008610</gtr:fundingRef><gtr:id>54029A41-0618-430F-A25A-01FABDDC31EB</gtr:id><gtr:outcomeId>gBR6LHBzt9h</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>372000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NHS RCD Fellowships</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5830990B-3D74-4885-A718-A8754E9AF724</gtr:id><gtr:outcomeId>8FEBEE3810B0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Hybridomas producing monoclonal antibodies to human LYVE-1 were licensed to Merck Millipore on a non-exclusive basis.The mAbs will be included in their catalogue for non-medical use.</gtr:description><gtr:grantRef>MC_U137884182</gtr:grantRef><gtr:id>86E4731D-ACAC-4916-8625-1D1EBEE1B627</gtr:id><gtr:impact>N.A.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58c813988d5045.87788147</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Licensing of monoclonal antibodies</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH Study Section</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>7F9C3616-7952-45DC-93A3-E572B4F0D14F</gtr:id><gtr:impact>Reviewed applications for research funding submitted to NIH</gtr:impact><gtr:outcomeId>54622947edf828.62305890</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of MRC Infection and Immunity Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>69A4820B-7467-4B94-A5AA-45415A339035</gtr:id><gtr:outcomeId>d7YHZS4oHJw</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lund University</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>AAD88689-468B-4107-9F0A-65AD0C01CE22</gtr:id><gtr:impact>Advised on appointment of prestigious Professorship</gtr:impact><gtr:outcomeId>54622abcf0e850.16610377</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Swiss National Science Foundation</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>299389B9-BEF8-4A3B-95BE-3DE4FAE6AE24</gtr:id><gtr:outcomeId>546228d54e1a84.56238619</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Polish Science Foundation</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>CFE67078-B6A8-4FBB-8D47-AC29B9288C36</gtr:id><gtr:impact>Reviewed biomedical science grant proposals submitted to Polish Government Research Board</gtr:impact><gtr:outcomeId>546229cb139697.57274896</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academy of Finland</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>26AD7E70-DCD2-43EE-A029-E488DF39ED84</gtr:id><gtr:impact>Advised on appointment of prestigious Professorship</gtr:impact><gtr:outcomeId>54622a6a6149e5.80776614</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Identified molecular markers induced in lymphatic vessels of murine metastatic tumours by comparison with normal tissue lymphatics. Confirmed expression also in human cancers.</gtr:description><gtr:id>120BDDF2-1769-49F2-8114-B5F7EEA91AAB</gtr:id><gtr:impact>Used lymphatics markers to predict metastasis in colorectal/head and neck cancers. Identified receptor molecules that are liely to be mechanistically involved in lymphatic metastasis of tumours.</gtr:impact><gtr:outcomeId>44FC968BBDB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tumour-induced lymphatic vessel markers</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Defined properties of mAbs generated against lymphatic vessel receptor as being function blocking for leukocyte trafficking in lymphatics</gtr:description><gtr:id>B6C44BB2-1E63-4098-B11F-BA9D6AA72B73</gtr:id><gtr:impact>Use of mAbs identifies lymphatic receptor as important for leukocyte movement from tissues to lymph nodes in inflammation</gtr:impact><gtr:outcomeId>33A86AB63EB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Function blocking antibodies</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Primary lymphatic endothelial cells isolated by immunomagnetic bead selection from human skin, mouse skin and human colorectal tissue</gtr:description><gtr:id>F8034728-DBB5-4846-8663-673C7C9760F4</gtr:id><gtr:impact>Ability to analyze molecular details of lymphatic vessel physiology and to establish various assays for cell adhesion / transmigration studies with cells of authentic phenotype</gtr:impact><gtr:outcomeId>34D29A02B97</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Primary lymphatic endothelial cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>First crystal showing molecular details of interaction between a hyaluronan receptor and its ligand hyaluronan. Determined structure in the case of the primary receptor CD44 that is involved in inflammatory leukocyte trafficking and tumour metastasis</gtr:description><gtr:id>AB9470DE-7B60-44BE-AE61-B0EC9040C604</gtr:id><gtr:impact>Major boost to fundamental biology. Template for design of small molecule inhibitors of CD44 function with possible therapeutic potential</gtr:impact><gtr:outcomeId>BFDB03EA9B3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Crystal structure of CD44 receptor ligand complex</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>41B87B5C-E3A7-45A4-9758-7BE3C0DE56C9</gtr:id><gtr:title>A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f7efe663cc0c0fba118e261cf7a763"><gtr:id>25f7efe663cc0c0fba118e261cf7a763</gtr:id><gtr:otherNames>Clasper S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>0CAFA3588F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4DDE6A6-1029-47CC-A8CB-10A248301341</gtr:id><gtr:title>The presence and absence of lymphatic vessels in the adult human intervertebral disc: relation to disc pathology.</gtr:title><gtr:parentPublicationTitle>Skeletal radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7afb7f0622456ec8ac8bcaa55eed1b4d"><gtr:id>7afb7f0622456ec8ac8bcaa55eed1b4d</gtr:id><gtr:otherNames>Kliskey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-2348</gtr:issn><gtr:outcomeId>E215F7D5075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA013E7F-7546-4C6D-AE5A-43FEB5201A73</gtr:id><gtr:title>Blocking development of a CD8+ T cell response by targeting lymphatic recruitment of APC.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c5a9c8be01312f74038c2cc7616212f"><gtr:id>0c5a9c8be01312f74038c2cc7616212f</gtr:id><gtr:otherNames>Teoh D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>jxB33fW3DhN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B52D0089-AA2A-4826-878A-D11FF9CDCD31</gtr:id><gtr:title>CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78294fa7e556472f7e89779e9f44c23"><gtr:id>f78294fa7e556472f7e89779e9f44c23</gtr:id><gtr:otherNames>Manzo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>9574379C0D8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9337F768-3BC2-4114-A605-55809237342F</gtr:id><gtr:title>Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448b5f7fd751cf272bebade77e3e8ec3"><gtr:id>448b5f7fd751cf272bebade77e3e8ec3</gtr:id><gtr:otherNames>Banerji S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>LjBXZE5tKdY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B72B0278-6CF9-4066-9D09-308810DD3772</gtr:id><gtr:title>Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.</gtr:title><gtr:parentPublicationTitle>Cell and tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/690fe92edb5a88440a8c4ed04bee5ca4"><gtr:id>690fe92edb5a88440a8c4ed04bee5ca4</gtr:id><gtr:otherNames>Vainionp?? N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0302-766X</gtr:issn><gtr:outcomeId>JYhmfgfttwZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>125B0D96-F317-46C3-91FF-4A4F270E768F</gtr:id><gtr:title>Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84d0c13ca535800eb245cd86cb31863c"><gtr:id>84d0c13ca535800eb245cd86cb31863c</gtr:id><gtr:otherNames>Gale NW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>ciu8UUki9ET</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48256059-44D8-4B70-AD89-676017E36BCD</gtr:id><gtr:title>Cell traffic and the lymphatic endothelium.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>B582irWv3mF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5096C57C-FD94-41C5-84B8-E0F79106B461</gtr:id><gtr:title>Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>m6AVy9m4cfW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30E91C6C-3739-4D77-AA5C-70599CA68FE5</gtr:id><gtr:title>First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4a5c850fe457e26d77c50c75e411bb3"><gtr:id>e4a5c850fe457e26d77c50c75e411bb3</gtr:id><gtr:otherNames>Van der Auwera I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>nt3UZzGtgYo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E6769F2-C5D3-4F8A-A4CC-7BFED75871ED</gtr:id><gtr:title>Lymphatic Regulation of Cellular Trafficking.</gtr:title><gtr:parentPublicationTitle>Journal of clinical &amp; cellular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46606e6b4b9cbcbe71270c0189081d2a"><gtr:id>46606e6b4b9cbcbe71270c0189081d2a</gtr:id><gtr:otherNames>Jackson DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54624d6c69aed9.71378638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9B16B8B-13EB-4322-9576-9DE12A80A861</gtr:id><gtr:title>A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6693be5bcb21b5cbed09267687bf2bf3"><gtr:id>6693be5bcb21b5cbed09267687bf2bf3</gtr:id><gtr:otherNames>Nightingale TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>kjDy75K3sib</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC5D8384-8695-4555-932B-CC1E30E93B96</gtr:id><gtr:title>Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.</gtr:title><gtr:parentPublicationTitle>Cornea</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba6110b24420dc880ca3d8c9f4b30225"><gtr:id>ba6110b24420dc880ca3d8c9f4b30225</gtr:id><gtr:otherNames>Cursiefen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0277-3740</gtr:issn><gtr:outcomeId>BqQAZqGAy1U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D715385-E200-4B09-A1A4-F2504B4AF1C5</gtr:id><gtr:title>Intratumoural lymphatics in benign and malignant soft tissue tumours.</gtr:title><gtr:parentPublicationTitle>Virchows Archiv : an international journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24db8e62c2102b1642d96010820deaab"><gtr:id>24db8e62c2102b1642d96010820deaab</gtr:id><gtr:otherNames>Mahendra G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0945-6317</gtr:issn><gtr:outcomeId>J7qPHnv5vwv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81F1A2AC-A537-4C15-A761-5EE6A0BFA7B5</gtr:id><gtr:title>Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/712e9c99616a2760cfc5d78252783afd"><gtr:id>712e9c99616a2760cfc5d78252783afd</gtr:id><gtr:otherNames>Bj?rndahl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>3350006E764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>347A4D27-4244-4215-A2A6-9C4155A7C788</gtr:id><gtr:title>Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.</gtr:title><gtr:parentPublicationTitle>Urologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed8f320eafa3ba62c93e69c550b4b307"><gtr:id>ed8f320eafa3ba62c93e69c550b4b307</gtr:id><gtr:otherNames>Heinzelbecker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-1439</gtr:issn><gtr:outcomeId>5460fcc1e62bf5.79836878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6322431C-EF57-4823-9377-D7FCB11F6239</gtr:id><gtr:title>Absence of lymphatics at the bone-implant interface: implications for periprosthetic osteolysis.</gtr:title><gtr:parentPublicationTitle>Acta orthopaedica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c78fa5be9ea72233e395b97d5bf51ef"><gtr:id>7c78fa5be9ea72233e395b97d5bf51ef</gtr:id><gtr:otherNames>Edwards J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1745-3674</gtr:issn><gtr:outcomeId>40B5096BCA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFE93938-8B43-402D-892E-70E91545E74A</gtr:id><gtr:title>Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dfb70302f4b1e57c25940682f26a7f5"><gtr:id>9dfb70302f4b1e57c25940682f26a7f5</gtr:id><gtr:otherNames>Wolny PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>VGEowQmS5kh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>485FFAB1-8831-4C14-936C-0AA6E5624C54</gtr:id><gtr:title>Preparing the &amp;quot;soil&amp;quot;: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c69b4e5bde95f9fbb23e43c3012d98e"><gtr:id>5c69b4e5bde95f9fbb23e43c3012d98e</gtr:id><gtr:otherNames>Qian CN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>cL1xFsk5Lkw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>091A50F3-E83F-40D7-B85E-40EAFD5CB995</gtr:id><gtr:title>Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448b5f7fd751cf272bebade77e3e8ec3"><gtr:id>448b5f7fd751cf272bebade77e3e8ec3</gtr:id><gtr:otherNames>Banerji S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>qhPrFiVmKrz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63001BBC-A8D4-4921-89F8-E96055EF4903</gtr:id><gtr:title>Molecular characterization of dermal lymphatic endothelial cells from primary lymphedema skin.</gtr:title><gtr:parentPublicationTitle>Lymphatic research and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0d0ea0a364e5678f365cfe1420f2cb2"><gtr:id>c0d0ea0a364e5678f365cfe1420f2cb2</gtr:id><gtr:otherNames>Ogunbiyi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1539-6851</gtr:issn><gtr:outcomeId>tGv6dN8kXeu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC8699C9-2A69-44E6-98BF-3DA7D89DDE07</gtr:id><gtr:title>Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis.</gtr:title><gtr:parentPublicationTitle>Cancer treatment and research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46606e6b4b9cbcbe71270c0189081d2a"><gtr:id>46606e6b4b9cbcbe71270c0189081d2a</gtr:id><gtr:otherNames>Jackson DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0927-3042</gtr:issn><gtr:outcomeId>p48Mem9bwkF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F967BC47-5809-40A9-9EE8-B4AC1BA5D02A</gtr:id><gtr:title>Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>hYP1W3YPRnn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A08A8E27-720C-40AB-A561-FA49FE797688</gtr:id><gtr:title>The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_16085_25_24006262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A5905E7-6949-4C43-937A-584D7004802F</gtr:id><gtr:title>Lymphatics and bone.</gtr:title><gtr:parentPublicationTitle>Human pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1e023136232b9c9573aadbb1077f53"><gtr:id>6f1e023136232b9c9573aadbb1077f53</gtr:id><gtr:otherNames>Edwards JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0046-8177</gtr:issn><gtr:outcomeId>kgqRRUbtAAc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5313656E-FAC6-4FE5-B7C4-0B61F70B2136</gtr:id><gtr:title>Immunohistochemical methods for measuring tissue lymphangiogenesis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f7efe663cc0c0fba118e261cf7a763"><gtr:id>25f7efe663cc0c0fba118e261cf7a763</gtr:id><gtr:otherNames>Clasper S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>HK8naVj8wqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>857EEDC9-32E1-44A9-AB15-99E07E7518A2</gtr:id><gtr:title>The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88ecd6b1bf0f8c429761830392d9bd57"><gtr:id>88ecd6b1bf0f8c429761830392d9bd57</gtr:id><gtr:otherNames>Chang YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Dc8CCsmBJcV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D91148A3-1459-4A6F-9725-9815A3204883</gtr:id><gtr:title>The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c81522567d0d1061915a5a3b1dfa769"><gtr:id>0c81522567d0d1061915a5a3b1dfa769</gtr:id><gtr:otherNames>Trojan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>HfXTKe1QcXf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DF11CED-86A3-43F4-B61A-6E335A0DB0DE</gtr:id><gtr:title>Control of dendritic cell trafficking in lymphatics by chemokines.</gtr:title><gtr:parentPublicationTitle>Angiogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-6970</gtr:issn><gtr:outcomeId>pm_16085_25_24232855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>666B3B8D-4E6B-4D7B-93AE-8FD6CE57316D</gtr:id><gtr:title>Immunological functions of hyaluronan and its receptors in the lymphatics.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46606e6b4b9cbcbe71270c0189081d2a"><gtr:id>46606e6b4b9cbcbe71270c0189081d2a</gtr:id><gtr:otherNames>Jackson DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>qSAvzb26PHB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA81D3A1-7DBD-4D6F-A9BC-399D5B0E5163</gtr:id><gtr:title>Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94a62d4a637c127688140a02afdfcdfc"><gtr:id>94a62d4a637c127688140a02afdfcdfc</gtr:id><gtr:otherNames>Royston D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>FF6C658D466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB83CF13-55BB-4BA6-B60D-FC7115E4C386</gtr:id><gtr:title>Role of lymphangiogenesis in epithelial ovarian cancer.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4433d78af30e0ee0b6ce2f8918dcb94"><gtr:id>e4433d78af30e0ee0b6ce2f8918dcb94</gtr:id><gtr:otherNames>Sundar SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>c8QJMaw1nXX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226416EF-A8A4-46F9-AA62-F1FE7699EABE</gtr:id><gtr:title>Renal cells activate the platelet receptor CLEC-2 through podoplanin.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dfa75813aa9e1324ba03e32c545cbd7"><gtr:id>7dfa75813aa9e1324ba03e32c545cbd7</gtr:id><gtr:otherNames>Christou CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>9B1614A9D9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF7604A9-280D-46F4-AABB-6DF08D5B8178</gtr:id><gtr:title>An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>dRfaZmNjwsH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12CBD048-7035-4164-96A5-D58CC4C05160</gtr:id><gtr:title>Structure function relationships in the lymphatic system and implications for cancer biology.</gtr:title><gtr:parentPublicationTitle>Cancer metastasis reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5487ab348f91bb02e14eb6e1ce3d7ea"><gtr:id>d5487ab348f91bb02e14eb6e1ce3d7ea</gtr:id><gtr:otherNames>Witte MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0167-7659</gtr:issn><gtr:outcomeId>A5pDWgrvBMS</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137884182</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>